Primary antibody deficiencies represent an underestimated comorbidity in asthma patients: efficacy of immunoglobulin replacement therapy in asthma control-Reference-Cited by-同舟云学术

Primary antibody deficiencies represent an underestimated comorbidity in asthma patients: efficacy of immunoglobulin replacement therapy in asthma control

Published:2022-11-14 Issue:6 Volume:60 Page:1227-1236
ISSN:0277-0903
Container-title:Journal of Asthma
language:en
Short-container-title:Journal of Asthma

Author:

Vivarelli Emanuele¹,Matucci Andrea¹^ORCID,Parronchi Paola²,Liotta Francesco²,Cosmi Lorenzo²,Rossi Oliviero¹,Cavigli Edoardo³,Vultaggio Alessandra¹

Affiliation:

1. Immunoallergology Unit, Careggi University Hospital, Florence, Italy

2. Department of Experimental and Clinical Medicine, Immunology and Cell Therapy Unit, Careggi University Hospital, Florence, Italy

3. Department of Emergency Radiology, Careggi University Hospital, Florence, Italy

Publisher

Informa UK Limited

Subject

Pulmonary and Respiratory Medicine,Immunology and Allergy,Pediatrics, Perinatology and Child Health

Link

https://www.tandfonline.com/doi/pdf/10.1080/02770903.2022.2140435

Reference33 articles.

1. Strategies Targeting Type 2 Inflammation: From Monoclonal Antibodies to JAK-Inhibitors

2. Severe Adult Asthmas: Integrating Clinical Features, Biology, and Therapeutics to Improve Outcomes

3. Control of asthma in real life: still a valuable goal?

4. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, 2021. Available from: www.ginasthma.org.

5. Asthma and Chronic Rhinosinusitis: How Similar Are They in Pathogenesis and Treatment Responses?

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IPINeT Ped-unPAD Study: Goals, Design, and Preliminary Results;Journal of Clinical Medicine;2024-07-24